A dangerous drug-resistant superbug is surging in European hospitals, spreading between patients and becoming increasingly harder to treat, the EU’s disease agency warns. Cases of bloodstream infections caused by treatment-resistant Klebsiella pneumoniae have increased by 72% between 2019 and 2025 — way off a target of cutting rates by 5% by 2030 — according to the latest bundle of reports from the European Centre for Disease Prevention and Control, out Wednesday. Infections linked to this bacterium, which have been climbing steadily for the past few years , are a significant threat to patients in hospitals and have a high mortality rate typically between 40% and 70%.
Wir zeigen den wichtigsten Punkt oeffentlich. Erstellen Sie ein kostenloses Konto, um den vollstaendigen Artikel zu lesen, ihn zu speichern, zu diskutieren und mit Markt- und OSINT-Kontext zu verbinden.
